alexa Abstract | Application of validated RP ? HPLC method for estimation of pharmacokinetic parameters of novel satranidazole formulation

Asian Journal of Biomedical and Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Satranidazole, a BCS class II antiprotozoal drug has poor solubility. In vitro dissolution studies have demonstrated enhanced solubility and improved dissolution rate of satranidazole solid dispersion. However in vivo studies are necessary to provide a proof of enhanced bioavailability and therapeutic efficacy of the formulated solid dispersion. Though bioanalytical methods for estimation of satranidazole have been reported, its application for bioequivalence studies of satranidazole solid dispersion is yet to be explored. The objective of the present study was to apply validated reversed phase high-performance liquid chromatography (RP-HPLC) method for in vivo estimation of satranidazole and compare various pharmacokinetic parameters of pure satranidazole and its solid dispersion. Satranidazole solid dispersion was formulated by solvent evaporation technique using Plasdone® S 630 as hydrophilic carrier. The validated assay procedure involved extraction of satranidazole and internal standard (IS) Tinidazole, from plasma by protein precipitation. The chromatographic method used Kromasil C18 (4.6 mm × 250 mm, 5μ) column. Mobile phase of phosphate buffer (0.01M, pH3.5): acetonitrile (65:35, v/v), was used at a flow rate of 1.0 mL/min. The eluate was monitored using a diode array detector set at 320 nm. Pure satranidazole and the formulated solid dispersion were administered orally (50 mg/kg) to male Wistar rats. Nominal retention times of IS and satranidazole were 5.5 and 7.7 min respectively. The method was found to be linear (R2 > 0.999) in the concentration range 0.5 – 70 μg/mL. Absolute recovery was > 90% for both analyte and IS. The lower limit of quantification was 0.5 μg/mL. Analyte and IS were found to be stable during the freeze/thaw cycles, benchtop stability and long term stability. Satranidazole solid dispersion on oral administration to male Wistar rats demonstrated 1.85 folds increase in Cmax and 164% increase in bioavailability as compared to pure satranidazole. However tmax values when compared using Wilcoxon rank sum test were found to be similar (p> 0.05). A specific, accurate, precise and reproducible RP-HPLC method was applied successfully for estimating the enhanced bioavailability and increase in Cmax of satranidazole solid dispersion.

To read the full article Peer-reviewed Article PDF image

Author(s): Dhat S Dumbre S Kokare C Sharma P Shrivastava B

Keywords

Satranidazole, high performance liquid chromatography, bioequivalence, plasma

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

ph[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords